Gold Sodium Thiomalate is a pharmaceutical drug that belongs to the class of disease-modifying antirheumatic drugs (DMARDs). It is primarily used for the treatment of rheumatoid arthritis, a chronic inflammatory condition affecting the joints.
Gold Sodium Thiomalate is administered via intramuscular injection. It contains gold in the form of a thiomalate complex, which is a compound that improves the stability and solubility of gold. This formulation allows for slow and steady release of gold into the body, enhancing its therapeutic effect.
The exact mechanism of action of Gold Sodium Thiomalate in the treatment of rheumatoid arthritis is not fully understood. Nonetheless, it is believed to help decrease inflammation in the affected joints, relieve pain, and reduce the progression of joint damage caused by the disease. It is also thought to modulate the immune response, although the specific immunomodulatory effects are not entirely clear.
As with any medication, Gold Sodium Thiomalate may have potential side effects, including gastrointestinal disturbances, skin reactions, hematological abnormalities, and symptoms related to gold toxicity. It is crucial for patients to be closely monitored for these adverse effects while using this drug.
In summary, Gold Sodium Thiomalate is a DMARD used for the management of rheumatoid arthritis. It contains a gold-thiomalate complex, which is administered by injection and is thought to reduce inflammation and joint damage associated with the disease.
